Figure 1.
Upregulation of ADHFE1 promotes accumulation of D-2-hydroxyglutarate in breast tumors. c-Myc signaling increases D-2-hydroxyglutarate (D-2HG) by increasing the availability of both the substrates [4-hydroxybutyrate (4-HB) and α-ketoglutarate (α-KG)] and iron for the ADHFE1 enzyme. ADHFE1 and D-2HG up-regulate reductive carboxylation of glutamine-derived α-KG, reactive oxygen species (ROS) formation, and histone methylation at H3K4me3, leading to increased acetyl coenzyme A (acetyl CoA) and fatty acid synthesis and epithelial-mesenchymal transition (EMT). SSA, succinic semialdehyde; H3K4me3, histone trimethylation at histone H3, lysine 4.